Revenue grew 61% year-over-year to 5.4 MSEK, driven by proprietary X-ray tube sales, while operating losses widened slightly. A successful rights issue raised 14 MSEK, supporting innovation and expansion into defense and new technologies.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.